Page last updated: 2024-08-21

methyl carbonate and ER-Negative PR-Negative HER2-Negative Breast Cancer

methyl carbonate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dong, T; Gao, T; Ma, H; Miao, L; Wu, T; Xu, H; Zhang, J; Zhao, C1

Other Studies

1 other study(ies) available for methyl carbonate and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Ginsenoside Rg3 liposomes regulate tumor microenvironment for the treatment of triple negative breast cancer.
    Drug development and industrial pharmacy, 2023, Volume: 49, Issue:1

    Topics: Animals; Cell Line, Tumor; Female; Ginsenosides; Humans; Liposomes; Mice; Quality of Life; Triple Negative Breast Neoplasms; Tumor Microenvironment

2023